Key Factor Supporting Genome Editing/Genome Engineering Market Development in 2025: Rise In The Prevalence Of Cancer And Other Genetic Disorders Drives The Genome Editing Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Genome Editing/Genome Engineering Market Size By 2025?
The market for genome editing or genome engineering has experienced a swift expansion in the last few years. Expected to escalate from $8.62 billion in 2024 to $10.2 billion in 2025, it will record a compound annual growth rate (CAGR) of 18.2%. The growth witnessed in the historical period is attributed to factors like enhanced research in the fields of genetics and genomics, a surge in genetic disorders, advancements in gene therapy, investments pumped into biotechnology and life sciences, the potential for applications in agriculture, and utilization in model organisms.

How Big Is the Genome Editing/Genome Engineering Market Size Expected to Grow by 2029?
Rapid expansion is anticipated for the genome editing/genome engineering market, projecting a growth to $20.81 billion by 2029, with an annual compound growth rate of 19.5%. This future growth can be linked to several factors including - the advent of prime editing, focus on regulatory and ethical frameworks, increased utilization in drug discovery, potential for treating genetic disorders, personalization for gene function studies, and escalating interest in epigenome editing. The forecast period will witness significant trends such as advancements in Crispr technology, growing therapeutic applications, the introduction of new genome editing tools, increased investments and partnerships, optimized delivery systems and the use of artificial intelligence in genome editing design.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Which Key Market Drivers Powering Genome Editing/Genome Engineering Market Expansion and Growth?
The increasing occurrence of cancer and other genetic disorders is forecasted to spur the expansion of the genome editing/genome engineering market. Essentially, cancer is a disease that involves uncontrolled and invasive growth of some body cells, which can then proliferate to other parts of the body. Genome editing offers a swift approach to manufacture immune cells and oncolytic viruses for treating cancer. For example, in February 2022, the World Health Organization (WHO), a Switzerland-based UN health agency, reported in an article that nearly 10 million fatalities, amounting to almost one in six deaths, were attributed to cancer, placing it as the main cause of death globally. Moreover, in June 2022, the Centers for Disease Control and Prevention (CDC), a U.S. national public health agency, noted in a published report that in 2019, the U.S. recorded a total of 1,752,735 newly diagnosed invasive cancer cases, among which 863,830 were women and 888,905 were men. The overall cancer incidence rate stood at 439 per 100,000 individuals. Hence, this uphill trend in the occurrence of cancer and other genetic disorders acts as an impetus for the growth of the genome editing and genome engineering market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Genome Editing/Genome Engineering Market?
The trend of implementing technological advancements in gene editing is becoming increasingly prominent in the genome editing/genome engineering market. The primary focus for major companies in this market is the development of innovative tech solutions to strengthen their standing. For example, in May 2022, a new and efficient gene editing method for insects was announced by researchers from Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spanish research university specializing in evolutionary biology. This method, known as Direct parental CRISPR (DIPA-CRISPR), is simple yet effective and involves the injection of materials into the developing eggs of female adults rather than embryos, potentially eliminating the need to microinject CRISPR material into insect embryos.

What Are the Emerging Segments in the Genome Editing/Genome Engineering Market?
The genome editing/genome engineering market covered in this report is segmented -

1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

Who Are the Global Leaders in the Genome Editing/Genome Engineering Market?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Which are the Top Profitable Regional Markets for the Genome Editing/Genome Engineering Industry?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8010

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.